EVAg

Access to rooms in animal facilities to perform animal trials by using highly contagious animal diesase viruses without zoonotic potential (3+ animal health). In our animal facilities we could accommodate e.g. fish, sheep, goats, pigs, cattle or poultry.

Access to UL infrastructure for learning/training on techniques related to virus isolation and characterization.

Access to rooms in animal facilities to perform animal trials with small animals up to conditions of risk group 2 (public health).

Access to rooms in animal facilities to perform animal trials up to conditions of risk group 2 (public health or animal health). In our animal facilities we could accommodate e.g. fish, sheep, goats, pigs, cattle or poultry.

Access to rooms in animal facilities to perform animal trials with small animals under risk group 3 conditions (public health or animal health).

Access to rooms in animal facilities to perform animal trials up to risk group 3 (public health) or 3+ (animal health). In our animal facilities we could accommodate e.g. fish, sheep, goats, pigs, cattle or poultry under BSL 3 conditions (public health and animal health).

Access to animal facilities to perform animal trials with small animals by using highly contagious animal diesase viruses without zoonotic potential (3+ animal health)

Virus whole genome sequencing

General presentation of lyophilization. Access to BSL3 and BSL3+ laboratories: Reminder of biosafety and biosecurity procedures. Overall presentation of our lab process in the framework of EVAg : - Lyophilization process on virus strains. Overall presentation of Cryotec lyophilizer for derived product preparation such as inactivated quality controls: - Lyophilization process on derived products. Infectivity test from viral culture to qRT-PCR.

We provide a service of strain isolation from clinical samples. This service is available fo any virus up to Risk Group 3.